BRIAN M FLYNN
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology MARLTON, NJ NPI 1548618705
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology NJ E.R. Squibb & Sons, L.L.C. All categories
General Payments — all program years on this page
$5,088.39
- Category: General Payments
- Program years: PY2020–2024
- Record count: 333
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $906.17 across 46 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $906.17 | 46 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $120.68 | 1 |
| ABBVIE INC. | $99.22 | 5 |
| UCB, Inc. | $86.62 | 5 |
| Lilly USA, LLC | $65.39 | 4 |
| SK Life Science, Inc. | $54.65 | 3 |
| Biogen, Inc. | $47.72 | 3 |
| Teva Pharmaceuticals USA, Inc. | $43.48 | 3 |
| Genentech USA, Inc. | $43.03 | 2 |
| Alexion Pharmaceuticals, Inc. | $37.06 | 2 |
| PFIZER INC. | $35.02 | 2 |
| Avadel CNS Pharmaceuticals, LLC | $33.95 | 2 |
| Amneal Pharmaceuticals LLC | $32.45 | 2 |
| Aucta Pharmaceuticals, Inc. | $25.11 | 2 |
| HARMONY BIOSCIENCES LLC | $23.78 | 1 |
| EISAI INC. | $19.77 | 1 |
| ARGENX US, INC. | $18.77 | 1 |
| Ceribell, Inc. | $18.19 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $17.89 | 1 |
| Neurocrine BioSciences, Inc. | $17.67 | 1 |
| Merz Pharmaceuticals, LLC | $17.59 | 1 |
| Noven Therapeutics, LLC | $16.96 | 1 |
| Lundbeck LLC | $16.21 | 1 |
| JAZZ PHARMACEUTICALS INC. | $14.96 | 1 |
By program year
Records — PY2024 (46)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.